TL;DR: Compliance failure in security printing is almost always a documentation gap, not a materials failure — the ink may pass every lab test but still fail customs clearance if the declaration chain is incomplete.
TL;DR: EU REACH SVHC threshold is 0.1% w/w per article — a concentration that functional ink formulations can breach without the converter realising, because the threshold applies to the finished printed article, not the ink as supplied.
What Failure Looks Like at the Border and Why It Usually Starts Upstream #
Brand owners evaluating security printing for the first time tend to focus on the authentication feature — the hologram, the taggant, the covert ink layer. What stops shipments is rarely the feature itself. It’s the paperwork trail that should have accompanied every material in that feature from raw chemical to finished carton.
The observable symptoms fall into three categories:
Customs hold or rejection — the shipment is detained because the importer cannot produce substance declaration documents for the security ink components. This happens most often on EU-bound shipments under REACH and on US-bound food-adjacent packaging under FDA 21 CFR.
Retail or brand compliance audit failure — an internal audit or a third-party brand audit flags missing Safety Data Sheets (SDS), absent migration test data, or a taggant supplier that hasn’t been qualified under the brand’s approved vendor list (what we internally call the AVL gate review).
Ink or substrate performance dispute — the security feature degrades in transit or fails authentication scanning, and neither the brand nor the converter can determine whether the root cause is formulation, substrate, or application because no process parameter records were kept.
| Symptom | Most Likely Root Cause | Regulatory Hook |
|---|---|---|
| Customs hold, EU destination | Missing REACH SVHC declaration or SDS | REACH Regulation (EC) No 1907/2006, Article 33 |
| FDA rejection, food-contact packaging | Insufficient migration test data for indirect contact | FDA 21 CFR §175–178 |
| Authentication failure in field | No in-process cure energy or density spec logged | ISO 2834 (ink layer evaluation), internal QC records |
| Brand audit failure | Taggant supplier not on AVL, no certificate of conformity | ISO 9001:2015 supply chain documentation clause |
| China domestic market rejection | Ink formulation not aligned with GB/T 26394 | GB/T 26394-2011 anti-counterfeiting printing standards |
The REACH Threshold Misunderstanding That Causes the Most Rework #
The misdiagnosis happens consistently at the same point: a converter receives a conformity declaration from their ink supplier stating the ink formulation is REACH-compliant. The brand signs off. The shipment is challenged at EU customs anyway.
The mechanism is this. REACH Article 33 — specifically the SVHC (Substances of Very High Concern) communication obligation — sets the 0.1% w/w threshold at the level of the finished article, not the ink as supplied in the can. A taggant ink that contains a solvent carrier including a listed SVHC at, say, 0.08% by weight of the ink may produce a dried ink film on a 2gsm application that, when the ink film weight is calculated as a fraction of the total article weight (the printed carton), sits well below 0.1%. But if the same SVHC-containing ink is applied at higher volume — a flood security coating at 8–12gsm on a compact article — the SVHC concentration in the finished article can cross the threshold.
The ink supplier declaration does not catch this. It is the converter’s responsibility to calculate article-level concentration, because the converter is the one who knows the actual application weight and the total article mass.
The confirmation test is straightforward: weigh a representative finished printed article, calculate the applied ink film weight from gravimetric before/after substrate samples (three specimens per batch is our minimum for this calculation), compute the mass fraction of each declared SVHC in the total article, and compare against the 0.1% w/w threshold. We run this calculation on what we track internally as the F-REG-04 article compliance worksheet — it’s a simple spreadsheet but it catches the issue before production runs, not after.
The threshold applies per SVHC substance, not per formulation. If an ink contains two listed SVHCs, both must be calculated separately. ECHA’s SCIP database submission (mandatory since January 2021 under Waste Framework Directive Article 9) requires article-level SVHC data, which is a second downstream trigger for the same calculation.
Corrective Actions Ranked by Impact and Implementation Cost #
-
Run article-level REACH calculation before production, not before shipment. This addresses the SVHC misdiagnosis above. Cost: engineer time, roughly 2–4 hours per new job. Covers roughly 70–80% of EU customs documentation issues we’ve encountered across our food and pharma adjacent security print jobs.
-
Obtain full SDS (GHS-compliant, 16-section) from every ink and taggant supplier, not just the formulator’s conformity letter. A conformity letter states compliance; an SDS discloses what the formulation contains. For food-contact or indirect-contact applications, supplement the SDS with a functional barrier analysis referencing FDA 21 CFR §175.300 or EU Regulation 10/2011 as applicable. This is non-negotiable for pharmaceutical serialisation packaging.
-
Add cure energy logging to every UV/EB security ink job. Under-cured UV ink is a migration risk and an authentication risk simultaneously. We specify minimum cure energy at 120–180 mJ/cm² for standard UV security inks (substrate and pigment loading affect the upper bound), logged per roll or per sheet batch. ISO 2834-2 covers test methods for evaluating ink film properties under specified cure conditions.
-
For China domestic market or cross-border China shipments, align with GB/T 26394-2011. This standard specifies anti-counterfeiting feature classification (Classes A, B, C by detectability level), minimum authentication feature performance thresholds, and documentation requirements for customs declaration. Many brand owners sourcing in China are unaware this standard exists — it is not optional for products in categories regulated under China’s anti-counterfeiting enforcement framework.
-
Commission ISTA 2A or equivalent transit testing on the final security print sample before mass production sign-off. Not primarily for the substrate — for the security feature. Holograms delaminate. Covert ink layers crack at score lines. Taggant particles separate from the binder under vibration. ISTA Procedure 2A at 10–75 Hz sweep replicates typical air and ground freight conditions. A failed transit test at sample stage costs one set of tooling. A failed transit test discovered at the brand’s QC costs a full production run.
Prevention — What to Specify Before You Place the Order #
Every security printing specification should include: ink supplier name and lot traceability method, SVHC declaration at article level (not ink level), cure energy range with pass/fail bounds, authentication feature performance threshold (e.g., hologram diffraction efficiency ≥ 70% at 550nm), and substrate grade with the same supplier qualification applied to the ink. For any market with serialisation requirements — EU Falsified Medicines Directive, US DSCSA, or China NMPA track-and-trace — add the variable data specification: minimum bar code grade per ISO/IEC 15415 (2D codes) or ISO/IEC 15416 (linear codes), both requiring grade C or above for regulated pharmaceutical applications.
The document to request from any security printing supplier at brief stage: a completed Regulatory Compliance Declaration covering REACH, RoHS, and the applicable food contact or pharmaceutical regulation for your target markets. If a supplier cannot provide this before sampling, that is a qualification signal worth taking seriously.
Specification Notes for Brand Partners #
When you brief us on a security or functional printing job, the three things that determine how quickly we can move to accurate quotation are: your target market (EU, US, China, or multi-market), the product category (food-adjacent, pharmaceutical, or general consumer goods), and the authentication feature type (overt, covert, forensic, or digital integration).
The brief gap that generates the most unnecessary sample iterations is leaving the substrate unspecified. Security inks and taggants are qualified against specific substrate surfaces — a covert ink validated on coated SBS 350gsm will not behave identically on uncoated kraft or on foil laminate. Substrate changes after ink qualification mean re-running cure calibration, adhesion testing, and in some cases repeating the article-level REACH calculation. Specifying the substrate in the initial brief, including the supplier if you have a preference, removes at least one iteration cycle.
Our standard sampling timeline for security printing is 18–25 working days from approved brief to first physical sample, assuming ink and taggant materials are in stock. Jobs requiring new taggant qualification or a forensic marker supply chain review extend to 35–40 working days. Multi-market compliance review (EU + US + China simultaneously) adds 5–8 working days on top of either baseline.
Frequently Asked Questions
Does a REACH-compliant ink declaration from my supplier mean my finished packaging is REACH-compliant?
No — and this is the distinction that causes the most compliance problems we see. The supplier declaration covers the ink formulation at point of sale. REACH Article 33 compliance for finished articles requires an article-level SVHC calculation based on the actual ink film weight applied to your specific substrate and article geometry. A 0.1% w/w concentration that clears at low application weight can exceed the threshold at high coverage. Calculate it at article level before you ship.
What’s the minimum bar code grade required for pharmaceutical serialisation packaging?
ISO/IEC 15415 grade C is the floor for 2D codes (DataMatrix) on EU FMD and US DSCSA compliant pharmaceutical packaging — and many brand owners spec grade B or above to allow for print-on-substrate degradation over the product shelf life. Grade D prints will fail automated verification scanners at dispensing points even if they passed inspection at the print facility.
Is GB/T 26394-2011 mandatory for all products sold in China?
It depends on product category and enforcement context. For products subject to China’s anti-counterfeiting regulatory framework — which includes tobacco, pharmaceuticals, alcohol, and an expanding list of regulated consumer goods — the standard’s Class A or B feature requirements are treated as enforceable in customs and market surveillance contexts. For general consumer goods without specific regulatory mandate, it functions more as a technical reference. Check the specific product category listing before assuming it doesn’t apply.
Can we add security features after the main print job is completed, as a separate converting step?
Technically yes, practically it creates compliance complications. If the security feature is applied by a second converter, the article-level REACH obligation spans two production steps with separate ink documentation trails. Cure energy records, substrate compatibility, and SDS chains need to cover both operations. We see adhesion failures at score lines most often on two-stage jobs where the security coating was applied without knowledge of the first-stage ink chemistry. Single-pass is preferable wherever the feature type allows it.
Our product ships to the EU, US, and Southeast Asia — do we need three separate compliance packages?
For EU and US, yes — the documentation requirements are substantively different (REACH/SCIP for EU, FDA 21 CFR for US food-contact or FMD for pharmaceuticals) and cannot be consolidated into a single declaration. Southeast Asia varies significantly by country: Singapore’s MAS and Malaysia’s packaging requirements are relatively aligned with EU frameworks, while Vietnam and Indonesia have their own national standards that may require separate testing. Our F-REG-04 compliance worksheet covers EU and US as standard; Southeast Asia market review is handled case-by-case based on destination country and product category.
Planning a packaging project? Contact our team to request a complimentary specification review and sample quote.
The REACH Article 33 customs hold scenario is painfully familiar — we had a shipment of 8,400 watch boxes detained in Rotterdam for 11 days in 2022 because our converter’s SDS for the UV-cure taggant ink didn’t disclose a benzophenone derivative that was sitting right at the 0.1% w/w threshold on the finished carton. The ink had cleared every internal QC test, optical density was in spec, authentication read fine. Nobody had mapped the threshold back to the article weight rather than the ink as supplied, which is exactly the gap this piece is describing. Cost us the Q4 launch window for that collection.
Ran into exactly this with a Shenzhen converter in Q3 2022 — the UV-curable taggant ink cleared every internal lab spec we had, but the SVHC declaration only covered the ink as supplied, not the concentration in the finished printed carton. The converter’s QA team genuinely didn’t know the 0.1% w/w threshold applied at the article level, not the formulation level. Took us six weeks and a third-party SGS migration report to clear the hold at Rotterdam.
The REACH Article 33 documentation gap is real, but it’s worth flagging that the 0.1% w/w threshold calculation gets genuinely complicated when you’re running a multi-layer carton where the security ink is one of six or seven printed layers — we had a customs hold at Rotterdam in 2023 because the SVHC concentration was compliant in the ink as applied but tipped over threshold once the converter’s technical team recalculated against the finished article weight including the board substrate. The declaration chain wasn’t wrong exactly, just scoped to the wrong reference mass.